mI
molmir Inc.
Japan · Biotech
molmir develops ways to observe molecular dynamics and uses that knowledge to identify new targets for medicines.
Product
The company builds on research into phase separation in living cells. Its technology examines how molecules move, interact and change shape, allowing researchers to investigate behaviour that conventional static models can miss.
molmir originated from Nara Medical University, AIST and Tokushima University. It applies its research to diseases including ALS and Alzheimer’s, working with academic and commercial partners on drug-discovery projects.
Funding history
5 rounds · 3 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | ¥300M | BP Capital Co., Ltd. — ParticipantHigin Capital Co., Ltd. — ParticipantMitsubishi UFJ Capital Co., Ltd. — ParticipantNanto Capital Partners — ParticipantSenshu Ikeda Capital Co., Ltd. — ParticipantUntroD Capital Japan, Inc. — Participant | |
| 22nd Innovation R&D Grant encouragement award | ¥1M | The Senshu Ikeda Bank, Ltd. — Participant | |
| FY2024 second MU-TECH research grant | ¥3M | Mitsubishi UFJ Technology Development Foundation — Participant | |
| Seed | Undisclosed | Mitsubishi UFJ Capital Co., Ltd. — ParticipantSenshu Ikeda Capital Co., Ltd. — ParticipantUntroD Capital Japan, Inc. — Participant | |
| Pre-seed | Undisclosed | KTX Corporation — ParticipantUntroD Capital Japan, Inc. — Participant |